• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchRegulus Therapeutics
    Picture of Regulus Therapeutics logo

    RGLS — Regulus Therapeutics News Story

    $8.140.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $563.57m
    • Enterprise Value
      $498.20m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RGLS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RGLS Dividends
    All News

    NASDAQ RESUMED AT 04:35 PM

    Picture of Regulus Therapeutics logoRegulus Therapeutics
    12/10/2021 21:35
    NASDAQ RESUMED  RGLS.O  AT 04:35 PM
    

    Recent news on Regulus Therapeutics

    See all news
    • Brief: Novartis Completes Acquisition Of Regulus Therapeutics

      25/06/2025 14:15
    • Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer

      23/06/2025 06:02
    • Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics

      27/05/2025 12:58
    • Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

      08/05/2025 21:52
    • Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

      05/05/2025 21:04

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.